cells for regenerative medicine
cells for regenerative medicine, Total:121 items.
The international standard classification for "cells for regenerative medicine" includes: Food microbiology , Protection against dangerous goods , Animal feeding stuffs , General methods of tests and analysis for food products , Dental materials , Surgical instruments and materials , Medical equipment in general , Biology. Botany. Zoology , Raw materials for rubber and plastics in general .
The Chinese standard classification for "cells for regenerative medicine" includes: Medical apparatus and devices in general , Food sanitation , Marking, packaging, transport and storage in general , Livestock and poultry feed and additive , Basic standards and general methods , Stomatologic device, equipment and material , Medical optical instrument and endoscope , Reclaimed rubber .
General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China
- GB/T 4789.30-2008 Microbiological examination of food hygiene - Examination of listeria monocytogenes
- GB 30000.22-2013 Rules for classification and labelling of chemicals—Part 22:Germ cell mutagenicity
- GB/T 16886.5-2017 Biological evaluation of medical devices―Part 5:Tests for in vitro cytotoxicity
- GB/T 42076.1-2022 Biotechnology—Cell counting—Part 1: General guidance on cell counting methods
- GB/T 4789.30-2003 Microbiological examination of food hygiene―Examination of Listeria monocytogenes
- GB/T 16886.5-2003 Biological evaluation of medical devices - Part 5: Test for in vitro cytotoxicity
海关总署
- SN/T 5159-2019 Chemicals-Transgenic rodent somatic and germ cell gene mutation assays
Professional Standard - Agriculture
- NY/T 800-2004 Enumeration of somatic cells in raw milk
- 284药典 四部-2020 3500 Biological Activity-Potency Assay 3526 Recombinant Human Granulocyte Macrophage Stimulating Factor Biological Activity Assay
- NY/T 1902-2010 Microbiological examination of Listeria monocytogenes in feeds
- 246药典 三部-2010 Appendix Ⅹ XE Recombinant human granulocyte-stimulating factor biological activity assay
- NY/T 2186.4-2012 Microbial Pesticide Toxicological Test Guidelines - Part 4: Cell Culture Study
- 1318药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Human Granulocyte Macrophage Stimulating Factor
- 337药典 三部-2020 Biological Activity-Potency Assay 3526 Human Granulocyte Macrophage Stimulating Factor Biological Activity Assay
- 308药典 三部-2015 Biological Activity - Potency Assay 3526 Recombinant Human Granulocyte Macrophage Stimulating Factor Biological Activity Assay General Rules 135
- 1324药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Human Interleukin-11
- 247药典 三部-2010 Appendix Ⅹ XF Determination of Biological Activity of Recombinant Human Granulocyte Macrophage Stimulating Factor
- GB 4789.30-1994 Food Hygiene Microbiological Testing Listeria Monocytogenes Testing
- 1320药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Bovine Basic Fibroblast Growth Factor
- 289药典 四部-2015 3500 Biological Activity-Potency Assay 3526 Recombinant Human Granulocyte Macrophage Stimulating Factor Biological Activity Assay
- 336药典 三部-2020 Biological Activity-Potency Assay 3525 Human Granulocyte Stimulating Factor Biological Activity Assay
- 1317药典 化学药和生物制品卷-2010 Chapter 18 Biological Products 4. Cytokine Recombinant Human Granulocyte Stimulating Factor
Professional Standard - Medicine
- YY/T 0930-2014 Medical endoscopes―Endotherapy device―Cytology brush11.040.90
- YY/T 0993-2015 Biological evaluation of medical devices―Nanomaterial:In vitro cytotoxicity tests(MTT assay and LDH assay)
- YY/T 0127.16-2009 Biological evaluation of medical devices used in dentistry.Part 2:Test method In Vitro mammalian chromosome aberration test
- YY/T 0127.18-2016 Biological evaluation of medical devices used in dentistry Part 18:Dentine barrier cytotoxicity test
- YY/T 0127.17-2014 Biological evaluation of medical devices used in dentistry―Part 17:Mouse lymphoma cells(TK)gene mutation test
- YY/T 1897-2023 Biological evaluation of nanomedical devices Genotoxicity test In vitro mammalian cell micronucleus test
- YY/T 1912-2023 Biological evaluation and testing of medical devices for soft tissue regeneration
Group Standards of the People's Republic of China
- T/CECCEDA 003.1-2023 Technical requirement of single-use materials in CAR-T production Part 1: Cell frozen bag、Cell storage bag
- T/SZAS 39-2021 Dataset of single-cell transcriptomics
- T/CECCEDA 002-2023 Manufacture practice of single-use materials in CAR-T production
- T/ZHYX 001-2024 General requirements for the preparation of endometrial regenerative cells derived from human menstrual blood for clinical use
- T/ZJBMQA 005-2019 High quality recycled fine aggregate
- T/CECCEDA 003.2-2023 Technical requirement of single-use materials in CAR-T production Part 2: Cell sap culture tank
Taiwan Provincial Standard of the People's Republic of China
- CNS 15030-21-2006 Classification and labelling of chemicals - Germ cell mutagenicity
- CNS 14393-5-2004 Biological evaluation of medical devices – Part 5:Tests for in vitro cytotoxicity
- CNS 14393.5-2004 Biological evaluation of medical devices – Part 5:Tests for in vitro cytotoxicity
国家市场监督管理总局、中国国家标准化管理委员会
- GB/T 38484-2020 Determination of the biological activity for plant hormone-related secondary metabolites. Cytological method
Professional Standard - Chemical Industry
- HG/T 4609-2014 Non blackness refined reclaimed rubber
国家食品药品监督管理局
- YY/T 1562-2017 Tissue engineering medical device products-Biomaterial scaffolds-Guide for cell viability evaluation
国家药监局
- YY/T 1688-2021 Medical devices for human assisted reproductive technology—A method for blastocyst cell staining and counting
British Standards Institution (BSI)
- BS PAS 84:2012 Cell therapy and regenerative medicine. Glossary
- PD ISO/TR 10993-55:2023 Biological evaluation of medical devices. Interlaboratory study on cytotoxicity
- PAS 157:2015 Evaluation of materials of biological origin used in the production of cell-based medicinal products. Guide
- BS EN ISO 10993-5:2009 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009)
- BS EN ISO 10993-5:1999 Biological evaluation of medical devices - Tests for in vitro cytotoxicity
- BS ISO 20391-1:2018 Biotechnology. Cell counting. General guidance on cell counting methods
- PAS 84-2008 Regenerative medicine-- Glossary PUBLICLY AVAILABLE SPECIFICATION
- BS PAS 157:2015 Evaluation of materials of biological origin used in the production of cell-based medicinal products. Guide
- BS ISO 24479:2024 Biotechnology. Cellular morphological analysis. General requirements and considerations for cell morphometry to quantify cell morphological features
- 23/30463781 DC BS ISO 18162. Biotechnology. Biobanking. Requirements for human neural stem cells derived from pluripotent stem cells
- 23/30466937 DC BS ISO 24479 Biotechnology — Cellular morphological analysis — General requirements and considerations for cell morphometry to quantify cell morphological features
SCC
- BS EN 30993-5:1994 Biological evaluation of medical devices-Tests for cytotoxicity, in vitro methods
- BS PD ISO/TR 10993-55:2023 Biological evaluation of medical devices-Interlaboratory study on cytotoxicity
- BS PAS 84:2008 Regenerative medicine. Glossary
- AAMI/ISO 10993-5:1999 Biological evaluation of medical devices - Part 5: Tests for In Vitro Cytotoxicity
- DANSK DS/EN ISO 10993-5:2009 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
- CAN/CSA-ISO 10993-5-01:2001 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
- CAN/CSA-ISO 10993.5-97:1997 Biological evaluation of medical devices - Part 5: Tests for cytotoxicity: in vitro methods
- NS-ISO 10993-5:1992 Biological evaluation of medical devices — Part 5: Tests for cytotoxicity: in vitro methods
- DANSK DS/ISO/TR 10993-55:2023 Biological evaluation of medical devices – Part 55: Interlaboratory study on cytotoxicity
- NS-EN ISO 10993-5:1999 Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:1999)
- 07/30160957 DC EN ISO 10993-5. Biological evaluation of medical devices. Part 5. Tests for in vitro cytotoxicity
- NS-EN ISO 10993-5:2009 Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009)
- AENOR UNE-EN ISO 10993-5:2009 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009)
- AWWA WQTC65976 Application of a Flow Cytometry Method to Quantify Bacterial Regrowth and Assimilable Organic Carbon in Distribution Systems
- DIN EN ISO 10993-5/A1 E:2009 Draft Document - Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:1999); English version prEN ISO 10993-5:2008, Amendment 1
- DIN EN ISO 10993-5 E:2007 Draft Document - Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO/DIS 10993-5:2007); German version prEN ISO 10993-5:2007
- DANSK DS/ISO 20391-1:2018 Biotechnology – Cell counting – Part 1: General guidance on cell counting methods
- BS 5736-10:1988 Evaluation of medical devices for biological hazards-Method of test for toxicity to cells in culture of extracts from medical devices
- CSA Z316.6-1995(R2000) Evaluation of Single Use Medical Sharps Containers for Biohazardous and Cytotoxic Waste
- CSA Z316.6-2002 Evaluation of Single-Use Medical Sharps Containers for Biohazardous and Cytotoxic Waste
Korean Agency for Technology and Standards (KATS)
- KS P ISO 10993-5-2023 Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity
- KS P ISO 10993-5:2018 Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity
- KS J ISO 20391-1:2019 Biotechnology — Cell counting — Part 1: General guidance on cell counting methods
- KS I ISO 10712-2023 Water quality-Pseudomonas putida growth inhibition test (Pseudomonas cell multiplication inhibition test)
- KS I ISO 10712-2008(2018) Water quality-Pseudomonas putida growth inhibition test (Pseudomonas cell multiplication inhibition test)
TH-TISI
- TIS 2395.5-2008 Biological evaluation of medical devices.part 5: tests for in vitro cytotoxicity
Association Francaise de Normalisation
- NF EN ISO 10993-5:2010 Biological evaluation of medical devices - Part 5: testing for in vitro cytotoxicity
- NF S99-501-5*NF EN ISO 10993-5:2010 Biological evaluation of medical devices - Part 5 : tests for in vitro cytotoxicity.
- NF S91-145:1988 Dentistry. Dental implants. Cytocompatibility. Study of cells attachment and spreading on the biomaterial.
- NF S99-505:1994 BIOLOGICAL EVALUATION OF MEDICAL DEVICES. PART 5 : TESTS FOR CYTOTOXICITY : IN VITRO METHODS. (EUROPEAN STANDARD EN 30993-5).
VN-TCVN
- TCVN 7391-5-2005 Biological evaluation of medical devices.Part 5: Tests for in vitro cytotoxicity
American National Standards Institute (ANSI)
- ANSI/AAMI/ISO 10993-5:2009(R2022) Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
- ANSI/AAMI/ISO 10993-5:2009 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
- ANSI/AAMI/ISO 10993-5:2009(2014) Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity
KR-KS
- KS P ISO 10993-5-2018(2023) Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity
- KS P ISO 10993-5-2018 Biological evaluation of medical devices — Part 5: Tests for in vitro cytotoxicity
- KS J ISO 20391-1-2019 Biotechnology — Cell counting — Part 1: General guidance on cell counting methods
GSO
- BH GSO ISO 10993-5:2017 Biological evaluation of medical devices -- Part 5: Tests for in vitro cytotoxicity
- GSO ISO 10993-5:2015 Biological evaluation of medical devices -- Part 5: Tests for in vitro cytotoxicity
- GSO ASTM F3206:2022 Standard Guide for Assessing Medical Device Cytocompatibility with Delivered Cellular Therapies
- BH GSO ASTM F3206:2023 Standard Guide for Assessing Medical Device Cytocompatibility with Delivered Cellular Therapies
South African Bureau of Standard
- SANS 10993-5:2003 Biological evaluation of medical devices Part 5: Tests for in vitro cytotoxicity
German Institute for Standardization
- DIN EN ISO 10993-5:2009-10 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009); German version EN ISO 10993-5:2009
- DIN 58932-2:1998 Haematology - Determination of the concentration of blood corpuscles in blood - Part 2: Characteristic quantities for erythrocytes (erythrocyte indices)
- DIN 58932-2:1998-06 Haematology - Determination of the concentration of blood corpuscles in blood - Part 2: Characteristic quantities for erythrocytes (erythrocyte indices)
- DIN EN ISO 10712:1996 Water quality - Pseudomonas putida growth inhibition test (Pseudomonas cell multiplication inhibition test) (ISO 10712:1995); German version EN ISO 10712:1995
RU-GOST R
- GOST ISO 10993-5-2011 Medical devices. Biological evaluation of medical devices. Part 5. Tests for in vitro cytotoxicity
- GOST R ISO 10993.5-1999 Medical devices. Biological evaluation of medical devices. Part 5. Tests for cytotoxicity: in vitro methods
International Organization for Standardization (ISO)
- ISO 10993-5:1999 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
- ISO 10993-5:1992 Biological evaluation of medical devices — Part 5: Tests for cytotoxicity: in vitro methods
- ISO 10993-5:2009 Biological evaluation of medical devices — Part 5: Tests for cytotoxicity: in vitro methods
- ISO/TR 10993-55:2023 Biological evaluation of medical devices — Part 55: Interlaboratory study on cytotoxicity
- ISO 20391-1:2018 Biotechnology - Cell counting - Part 1: General guidance on cell counting methods
- ISO/DIS 24479:2023 Biotechnology — Cellular morphological analysis — General requirements and considerations for cell morphometry to quantify cell morphological features
PH-BPS
- PNS ISO 10993-5:2021 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity
Danish Standards Foundation
- DS/EN 30993-5:1994 Biological evaluation of medical devices-Part 5:Tests for cytotoxicity-in vitro methods
- DS/EN ISO 10712:1996 Water quality - Pseudomonas putida growth inhibition test (Psedomonas cell multiplication inhibition test)
DIN
- DIN EN ISO 10993-5:1999 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:1999)
Spanish Association for Standardization (UNE)
- UNE-EN ISO 10993-5:2009 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009)
- UNE-EN ISO 10993-5:2000 BIOLOGICAL EVALUATION OF MEDICAL DEVICES. PART 5: TESTS FOR IN VITRO CYTOTOXICITY (ISO 10993-5:1999)
RO-ASRO
- STAS SR EN 30993-5-1996 Biological evaluation of medical devices -Part 5: Tests for cytotoxicity: in vitro methods
American Society for Testing and Materials (ASTM)
- ASTM F3206-17 Standard Guide for Assessing Medical Device Cytocompatibility with Delivered Cellular Therapies
- ASTM F2900-11 Standard Guide for Characterization of Hydrogels used in Regenerative Medicine
GOST
- GOST R ISO 20391-1-2023 Biotechnology. Cell counting. Part 1. General guidance on cell counting methods
- GOST R ISO 10993-5-2009 Medical devices. Biological evaluation of medical devices. Part 5. Tests for in vitro cytotoxicity
IT-UNI
- UNI ISO 20391-1:2021 Biotechnology - Cell counting - Part 1: General guidance on cell counting methods
Military Standards (MIL-STD)
- DOD A-A-51801-1987 FIXATIVE, CYTOLOGY (AEROSOL SPRAY)
European Committee for Standardization (CEN)
- EN ISO 10993-5:2009 Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009)
cell regeneration,regenerative medicine,cell regeneration,regenerative medicine,cells for regenerative medicine,Frontiers in Regenerative Medicine,medical regenerative medicine,cells for regenerative medicine,regenerative medicine therapy,The future of regenerative medicine,regenerative medicine and,future regenerative medicine,Cellular and Regenerative Medicine,regenerative medicine cell therapy,Regenerative Medicine and Cell Therapy,Medicine and Regenerative Medicine,Medicine and Regenerative Medicine,regenerative medicine therapy,Frontiers in Regenerative Medicine,The future of regenerative medicine